Molecular mechanisms of Tie2/Angiopoietin signaling initiation
Tie2/血管生成素信号传导启动的分子机制
基本信息
- 批准号:9321086
- 负责人:
- 金额:$ 44.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-01 至 2020-07-31
- 项目状态:已结题
- 来源:
- 关键词:AgonistAngiopoietin-2AngiopoietinsBindingBiochemicalBiologicalBiological AssayBiophysicsCell LineCell surfaceCellsCharacteristicsChemicalsComplementComplexCrystallizationDataEngineeringEventFluorescence Resonance Energy TransferGlycoproteinsGoalsIndividualInsectaIntegrinsKineticsLengthLigandsLigationLymphatic SystemMaintenanceMediatingMediator of activation proteinMethodsMolecularMonitorPhosphotransferasesPlayProductionPropertyProtein Tyrosine KinaseProteinsReceptor Protein-Tyrosine KinasesRoleSignal TransductionSpectrum AnalysisStructureSurfaceSystemTIE-2 ReceptorTechniquesThermodynamicsTransmembrane DomainVascular SystemWorkX-Ray Crystallographyanalytical ultracentrifugationangiogenesisbasebiological systemsbiophysical analysisexperimental studyextracellularin vivomicrocalorimetrymilligramoverexpressionreceptor
项目摘要
Abstract
The angiopoietins are a small class of secreted glycoproteins that play key roles in the maturation
and maintenance of the mammalian vascular and lymphatic systems. They exert their effects through the
Tie receptor tyrosine kinases. All four angiopoietins (Ang1-4) directly bind Tie2, while none of them binds
the related Tie1, although the latter has been shown to modulate the Ang/Tie2 signaling. Integrins, and in
particular a5b1, are involved in regulating Ang1-dependent angiogenesis and were shown to directly
interact with Tie2. The Ang/Tie signaling is unique among receptor kinase-ligand systems in that distinct
angiopoietin ligands, although all highly homologous, may function as agonist or antagonist in a context
dependent manner. A detailed understanding of the mechanisms of Angiopoietin/Tie signaling and their
precise function during angiogenesis requires a comprehensive structural and biophysical analysis of the
angiopoietins, of the Tie receptors and their co-receptors, as well as of their interactions. We will use X-ray
crystallography, combined with other biophysical, biochemical and cell-biological techniques, to study these
molecules. We have previously determined the structures of Tie2, Ang1, Ang2, as well as of the Tie2/Ang1
and Tie2/Ang2 complexes, revealing important and unique characteristics of Tie2 signaling initiation. We
also performed FRET-based studies on live cells to monitor the Tie1/Tie2 interactions on the cell surface.
An important conclusion of our experiments is that the distinct signaling properties of the individual
angiopoietins are likely the result of Tie2 co-receptors that respond differently to the different ligands.
Therefore, we now propose to study the molecular mechanisms by which co-receptors modulate, in a
regulated and cell/context-dependent manner, the Ang/Tie2 signaling events. We specifically propose to
investigate the roles of Tie1 and intergrin a5b1. Finally, our ultimate goal is to determine crystal structures of
the complete Tie2 receptor, including its transmembrane region, alone and in complex with ligands and co-
receptors, and we will work on the production and structural characterization of functional full-length Tie
proteins.
+ PHS 398/2590 (Rev. 05/01)
摘要
血管生成素是一小类分泌性糖蛋白,在成熟中起关键作用
以及维持哺乳动物的血管和淋巴系统。它们通过
Tie受体酪氨酸激酶。所有四种血管生成素(Ang 1 -4)都直接结合Tie 2,而它们都不结合Tie 2。
相关的Tie 1,尽管后者已被证明可调节Ang/Tie 2信号传导。整合素,
特别是a5 b1,参与调节Ang 1依赖性血管生成,并显示直接
与Tie 2互动。Ang/Tie信号传导在受体激酶-配体系统中是独特的,
血管生成素配体,尽管都是高度同源的,但在某些情况下可以作为激动剂或拮抗剂起作用
依赖的方式。详细了解血管生成素/Tie信号转导机制及其在血管生成中的作用。
在血管生成过程中的精确功能需要对血管生成的细胞进行全面的结构和生物物理分析。
血管生成素、Tie受体和它们的共受体以及它们的相互作用。我们将使用X光
晶体学,结合其他生物物理,生物化学和细胞生物学技术,研究这些
分子。我们以前已经确定了Tie 2,Ang 1,Ang 2以及Tie 2/Ang 1的结构
和Tie 2/Ang 2复合物,揭示了Tie 2信号起始的重要和独特的特征。我们
还对活细胞进行了基于FRET的研究,以监测细胞表面的Tie 1/Tie 2相互作用。
我们实验的一个重要结论是,个体的独特信号特性
血管生成素可能是Tie 2共受体对不同配体的不同反应的结果。
因此,我们现在建议研究共受体调节的分子机制,
调节和细胞/环境依赖性的方式,Ang/Tie 2信号传导事件。我们特别建议,
研究Tie 1和整合素a5 b1的作用。最后,我们的最终目标是确定
完整的Tie 2受体,包括其跨膜区,单独的和与配体和共-
受体,我们将致力于生产和功能全长Tie的结构表征
proteins.
+ PHS 398/2590(Rev.05/01)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DIMITAR B NIKOLOV其他文献
DIMITAR B NIKOLOV的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DIMITAR B NIKOLOV', 18)}}的其他基金
Targeting the alpha secretase ADAM10 for the treatment of Alzheimer's disease
靶向 α 分泌酶 ADAM10 治疗阿尔茨海默病
- 批准号:
10590899 - 财政年份:2022
- 资助金额:
$ 44.81万 - 项目类别:
Molecular mechanisms of Tie2/Angiopoietin signaling initiation
Tie2/血管生成素信号传导启动的分子机制
- 批准号:
9159077 - 财政年份:2016
- 资助金额:
$ 44.81万 - 项目类别:
Function-blocking anti-ADAM protease antibodies for inhibition of tumorigenesis
用于抑制肿瘤发生的功能阻断性抗 ADAM 蛋白酶抗体
- 批准号:
9024489 - 财政年份:2015
- 资助金额:
$ 44.81万 - 项目类别:
Function-blocking anti-ADAM protease antibodies for inhibition of tumorigenesis
用于抑制肿瘤发生的功能阻断性抗 ADAM 蛋白酶抗体
- 批准号:
8881452 - 财政年份:2015
- 资助金额:
$ 44.81万 - 项目类别:
STRUCTURAL STUDIES OF EPH RECEPTORS AND EPHRINS
EPH 受体和 EHRINS 的结构研究
- 批准号:
8361611 - 财政年份:2011
- 资助金额:
$ 44.81万 - 项目类别:
STRUCTURAL STUDIES OF EPH RECEPTORS AND EPHRINS
EPH 受体和 EHRINS 的结构研究
- 批准号:
8169221 - 财政年份:2010
- 资助金额:
$ 44.81万 - 项目类别:
SIGNAL TRANSDUCTION MECHANISMS OF CELL-SURFACE LIGAND-RECEPTOR SYSTEMS
细胞表面配体受体系统的信号转导机制
- 批准号:
7721231 - 财政年份:2008
- 资助金额:
$ 44.81万 - 项目类别:
DETERMINATION OF THE STRUCTURE OF APG7 BY MAD
MAD 测定 APG7 的结构
- 批准号:
7721329 - 财政年份:2008
- 资助金额:
$ 44.81万 - 项目类别:
Novel Small-Molecule Inhibitors of the Tie2/Angiopoietin Interactions and Signali
Tie2/血管生成素相互作用和信号的新型小分子抑制剂
- 批准号:
7426768 - 财政年份:2007
- 资助金额:
$ 44.81万 - 项目类别:
相似国自然基金
膀胱癌细胞通过调控淋巴内皮细胞angiopoietin-2修饰促进淋巴转移的分子机制研究
- 批准号:
- 批准年份:2021
- 资助金额:54.7 万元
- 项目类别:面上项目
中药单体蟾毒灵调控Angiopoietin-2蛋白分泌抑制肝癌血管生成的分子机制研究
- 批准号:81603348
- 批准年份:2016
- 资助金额:17.0 万元
- 项目类别:青年科学基金项目
肿瘤包绕型血管关键分子Angiopoietin-2在肝癌的表达调控机制及其功能
- 批准号:81602151
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
炎症与淋巴管再生: Angiopoietin-2的调控作用
- 批准号:30772262
- 批准年份:2007
- 资助金额:30.0 万元
- 项目类别:面上项目
相似海外基金
Angiopoietin-2/Tie2 signaling regulation of liver metastasis in pancreatic neuroendocrine tumors
血管生成素2/Tie2信号对胰腺神经内分泌肿瘤肝转移的调控
- 批准号:
10746299 - 财政年份:2023
- 资助金额:
$ 44.81万 - 项目类别:
Angiopoietin-2 Signaling Targeted Therapeutics for Arteriovenous Malformations
血管生成素 2 信号传导靶向治疗动静脉畸形
- 批准号:
10420883 - 财政年份:2022
- 资助金额:
$ 44.81万 - 项目类别:
Angiopoietin-2/Tie2 signaling regulation of liver metastasis in pancreatic neuroendocrine tumors
血管生成素2/Tie2信号对胰腺神经内分泌肿瘤肝转移的调控
- 批准号:
10521805 - 财政年份:2022
- 资助金额:
$ 44.81万 - 项目类别:
Angiopoietin-2/Tie2 signaling regulation of liver metastasis in pancreatic neuroendocrine tumors
血管生成素2/Tie2信号对胰腺神经内分泌肿瘤肝转移的调控
- 批准号:
10663955 - 财政年份:2022
- 资助金额:
$ 44.81万 - 项目类别:
Angiopoietin-2/Tie2 signaling regulation of liver metastasis in pancreatic neuroendocrine tumors
血管生成素2/Tie2信号对胰腺神经内分泌肿瘤肝转移的调控
- 批准号:
10932452 - 财政年份:2022
- 资助金额:
$ 44.81万 - 项目类别:
Angiopoietin-2 Signaling Targeted Therapeutics for Arteriovenous Malformations
血管生成素 2 信号传导靶向治疗动静脉畸形
- 批准号:
10586049 - 财政年份:2022
- 资助金额:
$ 44.81万 - 项目类别:
Mechanisms driving endothelial angiopoietin-2 expression and vascular dysfunction during pediatric sepsis
小儿脓毒症期间内皮血管生成素 2 表达和血管功能障碍的驱动机制
- 批准号:
10684768 - 财政年份:2021
- 资助金额:
$ 44.81万 - 项目类别:
Mechanisms driving endothelial angiopoietin-2 expression and vascular dysfunction during pediatric sepsis
小儿脓毒症期间内皮血管生成素 2 表达和血管功能障碍的驱动机制
- 批准号:
10347958 - 财政年份:2021
- 资助金额:
$ 44.81万 - 项目类别:
IDENTIFICATION OF A NOVEL ANGIOPOIETIN 2 SIGNALLING CENTRE IN THE EMBRYONIC HAEMATOPOIETIC STEM CELL NICHE
胚胎造血干细胞生态位中新型血管生成素 2 信号中心的鉴定
- 批准号:
MR/R018081/1 - 财政年份:2018
- 资助金额:
$ 44.81万 - 项目类别:
Research Grant
The role of angiopoietin-2 in anaphylactic shock
血管生成素2在过敏性休克中的作用
- 批准号:
16K11428 - 财政年份:2016
- 资助金额:
$ 44.81万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




